RT Journal Article
SR Electronic
T1 Prospective genomic surveillance and characterization of respiratory syncytial virus in Minnesota, USA – July 2023 to February 2024
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.10.24310215
DO 10.1101/2024.07.10.24310215
A1 Evans, Daniel
A1 Kunerth, Henry
A1 Mumm, Erica
A1 Namugenyi, Sarah
A1 Plumb, Matthew
A1 Bistodeau, Sarah
A1 Cunningham, Scott A.
A1 Schmitt, Bryan
A1 Martin, Karen
A1 Como-Sabetti, Katherine
A1 Lynfield, Ruth
A1 Wang, Xiong
YR 2024
UL http://medrxiv.org/content/early/2024/07/10/2024.07.10.24310215.abstract
AB We expanded Minnesota’s viral genomic surveillance program to include respiratory syncytial virus (RSV). We performed whole-genome sequencing of 575 specimens collected at Minnesota healthcare facilities from July 2023 to February 2024. Subtypes A and B exhibited differences in their genomic landscapes, and we identified 23 clusters of genetically identical genomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by CDC Epidemiology and Laboratory Capacity grant NU50CK000508 and Pathogen Genomics Centers of Excellence grant NU50CK000628.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Health Protection Bureau of the Minnesota Department of Health waived ethical approval for this study, since all data collection and analysis were conducted as a component of public health surveillance activities subject to Minnesota Reporting Rules.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll genome sequencing reads from this study are publicly available on NCBI under BioProject number PRJNA1048457. De-identified epidemiological data in the present study may be requested, subject to HIPAA and Minnesota state law. https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA1048457